Stay updated with breaking news from Ruyu wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ XtalPi, Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced that Dr. Sarah. ....
/PRNewswire/ XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi. ....
/PRNewswire/ Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery. ....
XtalPi Invests in Novel Target Discovery Biotech PhoreMost in Oversubscribed Series B Financing prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ XtalPi Inc., an Artificial Intelligence (AI) drug discovery and development technology company, is presenting virtually at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2021 at 12:10 PM ET. The live webcast with XtalPi Chief Strategy Officer, Dr. Alan Jiang, will be accessible at: https://jpmorgan.metameetings.net/events/healthcare21/sessions/35249-xtalpi-inc/webcast XtalPi is known for its Intelligent Digital Drug Discovery and Development (ID4) platform that addresses key drug properties and research challenges throughout the R&D process, from drug discovery to drug solid state development. By integrating quantum physics, artificial intelligence, and cloud high-performance computing, XtalPi has developed a series of ....